SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001144204-18-053463
Filing Date
2018-10-11
Accepted
2018-10-11 15:16:30
Documents
73

Document Format Files

Seq Description Document Type Size
1 S-1 tv504484_s1.htm S-1 1491371
2 EXHIBIT 23.1 tv504484_ex23-1.htm EX-23.1 2504
3 GRAPHIC tv504484_img01.jpg GRAPHIC 10538
  Complete submission text file 0001144204-18-053463.txt   10212863

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20180630.xml EX-101.INS 3068875
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20180630.xsd EX-101.SCH 54727
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20180630_cal.xml EX-101.CAL 41108
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20180630_def.xml EX-101.DEF 352485
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20180630_lab.xml EX-101.LAB 386910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20180630_pre.xml EX-101.PRE 413171
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-227786 | Film No.: 181118269
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1